Millipore Sigma Vibrant Logo

AB6001 Anti-MMP-9 Antibody, NT

View Products on
100 µg  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
Solicitar precio
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ofertas especiales


      Póngase en contacto con el Servicio de Atención al Cliente


      Replacement Information

      Ofertas especiales

      Tabla espec. clave

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, R, Mk, Pm, Eq, Ca, PoWBRbAffinity PurifiedPolyclonal Antibody
      Catalogue NumberAB6001
      DescriptionAnti-MMP-9 Antibody, NT
      Alternate Names
      • 92 kDa gelatinase
      • 92 kDa type IV collagenase
      • Gelatinase B
      • macrophage gelatinase
      • matrix metallopeptidase 9
      • matrix metalloproteinase 9
      • type V collagenase
      Background InformationAll cells within tissues are surrounded by an extracellular matrix (ECM) giving the tissues shape and structure. The ECM is constantly being remodeled and constant communication is maintained between cells through this matrix. Secreted proteins, termed matrix metalloproteinases (MMPs), are involved in the modulation of cell matrix interactions. MMPs are Zn2+ binding endopeptidases that degrade various components of the ECM. MMPs are enzymes implicated in normal and pathologic tissue remodeling processes, wound healing, angiogenesis, and tumor invasion. These enzymes are very potent when active, and are associated with extracellular space inhibitors called TIMPs (tissue inhibitors of matrix metalloproteinases).

      MMP9, also known as gelatinase B, is a secreted enzyme which degrades the interstitial collagens, types I, II, and III and is produced by normal alveolar macrophages and granulocytes.
      Product Information
      FormatAffinity Purified
      HS Code3002 15 90
      • HL-60 plus PMA conditioned media
      PresentationPurified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.05% sodium azide.
      Quality LevelMQ100
      ApplicationAnti-MMP-9 Antibody, N-terminus is an antibody against MMP-9 for use in WB.
      Key Applications
      • Western Blotting
      Biological Information
      ImmunogenKLH-conjugated synthetic peptide corresponding to the N-terminus of MMP-9.
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      SpecificityThe antibody recognizes human MMP-9. It does not cross react with MMP-1 or MMP-2.
      Species Reactivity
      • Human
      • Rat
      • Monkey
      • Primate
      • Horse
      • Canine
      • Pig
      Species Reactivity NoteHuman. Predicted to react with rat, monkey, primate, horse, dog, and pig based on 100% sequence homology.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryProteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq]
      Gene Symbol
      • MMP9
      • CLG4B
      • GELB
      • MMP-9
      Purification MethodAntigen Affinity Purified
      UniProt Number
      UniProt SummaryFUNCTION: May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly-|-Leu bond. Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments. Degrades fibronectin but not laminin or Pz-peptide.

      CATALYTIC ACTIVITY: Cleavage of gelatin types I and V and collagen types IV and V.

      Cofactor Binds 2 zinc ions per subunit.

      Binds 3 calcium ions per subunit.

      ENZYME REGULATION: Inhibited by histatin-3 1/24 (histatin-5).

      SUBUNIT STRUCTURE: Exists as monomer, disulfide-linked homodimer, and as a heterodimer with a 25 kDa protein. Macrophages and transformed cell lines produce only the monomeric form.

      SUBCELLUAR LOCATION: Secreted › extracellular space › extracellular matrix Probable.

      TISSUE SPECIFICTY: Produced by normal alveolar macrophages and granulocytes.

      INDUCTION: Activated by 4-aminophenylmercuric acetate and phorbol ester.

      DOMAIN: The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.

      PTM: Processing of the precursor yields different active forms of 64, 67 and 82 kDa. Sequentially processing by MMP3 yields the 82 kDa matrix metalloproteinase-9.

      N- and O-glycosylated.

      INVOLVEMENT IN DISEASE: Defects in MMP9 may be a cause of susceptibility to lumbar disk herniation (LDH) [MIM:603932]. LDH is the predominant cause of low-back pain and unilateral leg pain.

      MISCELLANEOUS: In the arthritis patient this enzyme might contribute to the pathogenesis of joint destruction and might constitute a useful marker of disease status.

      SEQUENCE SIMILARITIES: Belongs to the peptidase M10A family.

      Contains 3 fibronectin type-II domains.

      Contains 4 hemopexin-like domains.
      Molecular Weight92kDa (pro-form) and 88kDa (active form)
      Physicochemical Information
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated on a representative lot by Western blot using an HL-60 cell lysate supplemented with a PMA conditioned media.

      Western Blot Analysis: 0.5 µg/ml of this antibody detected MMP-9 on 10 µg of HL-60 plus PMA conditioned media.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Global Trade Item Number
      Número de referencia GTIN
      AB6001 04053252514685


      Anti-MMP-9 Antibody, NT Ficha datos de seguridad (MSDS)


      Ficha técnica de seguridad del material (MSDS) 

      Anti-MMP-9 Antibody, NT Certificados de análisis

      CargoNúmero de lote
      Anti-MMP-9, N-terminus - 2140066 2140066
      Anti-MMP-9, N-terminus - 2411907 2411907
      Anti-MMP-9, N-terminus - 2459053 2459053
      Anti-MMP-9, N-terminus - 1998944 1998944
      Anti-MMP-9, N-terminus - 2029643 2029643
      Anti-MMP-9, N-terminus - 2309346 2309346
      Anti-MMP-9, N-terminus - 2500558 2500558
      Anti-MMP-9, N-terminus - 3311777 3311777
      Anti-MMP-9, N-terminus - 4035060 4035060
      Anti-MMP-9, N-terminus - NG17342 NG17342

      Referencias bibliográficas

      Visión general referenciasPub Med ID
      Synaptic plasticity mediating cocaine relapse requires matrix metalloproteinases.
      Smith, AC; Kupchik, YM; Scofield, MD; Gipson, CD; Wiggins, A; Thomas, CA; Kalivas, PW
      Nature neuroscience  17  1655-7  2014

      Mostrar resumen
      25326689 25326689